Development of an Orally Bioavailable LCK PROTAC Degrader As a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia.
JOURNAL OF MEDICINAL CHEMISTRY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF MEDICINAL CHEMISTRY(2024)